Clinical spectrum and outcomes of idiopathic inflammatory myopathies at Chris Hani Baragwanath Academic Hospital

Simple item page
dc.contributor.authorBirch, Candice Tatum
dc.date.accessioned2024-03-12T10:04:59Z
dc.date.available2024-03-12T10:04:59Z
dc.date.issued2024
dc.descriptionA research report submitted in partial fulfilment of the requirement for the degree of Master of Medicine (MMed) in Internal Medicine to the Faculty of Health Sciences, University of the Witwatersrand, School of Clinical Medicine, Johannesburg, 2023
dc.description.abstractBackground: Idiopathic inflammatory myopathies (IIM) are rare diseases for which there is a paucity of data in Africa. We undertook a retrospective records review of clinical and laboratory features of patients with IIM attending a tertiary service in Gauteng, South Africa. Patients and methods: Case records of patients seen between January 1990 and December 2019 and fulfilling the Bohan and Peter criteria for IIM were reviewed for demographics, clinical features, special investigations and drug therapy. Results: Of 94 patients included in the study, 65 (69,1%) had dermatomyositis (DM) and 29 (30,9%) had polymyositis (PM). Overall, the mean (SD) age at presentation and disease duration were 41,5 (13,6) and 5,9 (6,2) years, respectively. 88 (93,6%) were Black Africans. The most common cutaneous features in DM patients were Gottron’s lesions (72,3%) and abnormal cuticular overgrowth (67,7%). Dysphagia was the most common extra-muscular feature (31,9%), more so in PM than DM (p=0,02). Creatine kinase, total leucocyte count and CRP were similarly higher in PM than DM patients (p=0,006, 0,002, 0,01, respectively). Anti-nuclear and anti-Jo-1 antibodies were positive in 62,2% and 20,4% of patients tested, respectively, the latter significantly more in PM than DM patients (OR=5.1, p=0,03) and more likely to be positive with ILD (p=0,001). Corticosteroids were prescribed in all patients, 89,4% had additional immunosuppressive drugs and 6,4% required intensive/high care. Malignancies occurred in three patients, all of whom had DM. There were seven known deaths. Conclusion: The present study provides further insights into the spectrum of clinical features of IIM, especially cutaneous features of DM, anti-Jo-1 antibodies and associated ILD, in a cohort of predominantly black African patients.
dc.description.librarianTL (2024)
dc.facultyFaculty of Health Sciences
dc.identifier.urihttps://hdl.handle.net/10539/37826
dc.language.isoen
dc.rights.holderUniversity of the Witwatersrand, Johannesburg
dc.schoolSchool of Clinical Medicine
dc.subjectIdiopathic inflammatory myopathies
dc.subjectClinical spectrum
dc.subject.otherSDG-3: Good health and well-being
dc.subject.otherSDG-16: Peace, justice and strong institutions
dc.titleClinical spectrum and outcomes of idiopathic inflammatory myopathies at Chris Hani Baragwanath Academic Hospital
dc.typeDissertation
Files
Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Abstract (004) (4).pdf
Size:
78.25 KB
Format:
Adobe Portable Document Format
Download
Thumbnail Image
Name:
Mmed.pdf
Size:
401.13 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.43 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Electronic Theses and Dissertations (Masters)